STAT January 12, 2022
It would be crazy for members of Congress to introduce a bill mandating that Medicare pay for an expensive cancer screening test backed by zero proof that it saves lives. It would be even crazier for the American Cancer Society to argue that mandating coverage for this unproven, expensive test would somehow address health disparities.
Crazy, but true.
The Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021 is a bipartisan effort that currently has 144 cosponsors in the House of Representatives and 30 cosponsors in the Senate. It would require Medicare to cover annual genomic sequencing of blood for the purpose of “early detection of cancer across many cancer types.”
Screening for cancer, or any other disease for that...